The latest leukaemia news
Marker for therapy response in AML identified
With the combination of the drugs Venetoclax and 5-Azacitidine, a new, effective and more tolerable…
Browsing: Leukaemia
Targeting menin induces responses in acute leukaemia with KMT2A rearrangements or NPM1 mutations
Researchers from The University of Texas MD Anderson Cancer Center showed that inhibiting menin with revumenib, previously…
Study unravels a cause of resistance to novel drug in patients with acute leukaemia
A new targeted drug has not only sparked remissions in patients with a common form…
Blood test identifies acute myeloid leukaemia patients at greater risk for relapse after bone marrow transplant
A small portion of adults in remission from a deadly blood cancer had persisting mutations…
Novel role of RNA editing by ADAR2 in core binding factor acute myelogenous leukaemia
A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of…
Drug combination shows potential in aggressive leukaemia
Despite recent therapeutic advances, acute myeloid leukaemia (AML) continues to be associated with poor outcomes…
UNSW researchers receive more than $5.9m in Cancer Institute NSW grants
Professor John Pimanda receives the new Translational Program Grant for his team’s work with acute myeloid…
Study reveals how chronic blood cancer transitions to aggressive disease
A type of chronic leukaemia can simmer for many years. Some patients may need treatment…
Inflammation levels tied to severity of blood cancer
Severe inflammation weakens the body’s ability to kill cancerous blood cells in people with acute…
ASH 2022: Striving to improve treatment options for acute myeloid leukaemia
If there is one thing a cancer patient wants beyond fast, effective treatment – it…